Menopause and perimenopause can affect weight through changing estrogen levels, sleep disruption, appetite changes, insulin sensitivity, stress response and muscle loss
Your NAD+ levels drop steadily with age, and the harder your bodys working (physically, mentally, emotionally), the more NAD+ you burn through
Key Takeaway: Freezing compounded tirzepatide destroys its molecular structure, leading to a loss of efficacy and potential safety risks
Why is it important to inject the water down the side of the vial
Acronyms A1C - Hemoglobin A1C ADA - American Diabetes Association CVD - Cardiovascular disease DM - Diabetes mellitus FBS - Fasting blood sugar GFR - Glomerular filtration rate GI - Gastrointestinal GLP-1 - Glucagon-like peptide-1 OSA - Obstructive sleep apnea RCT - Randomized controlled trial T2DM - Type 2 diabetes mellitus Thyroid C-cell tumor = Thyroid medullary tumor DRUGS IN CLASS Dual GLP-1 and GIP agonists Tirzepatide (Mounjaro) - marketed for diabetes Tirzepatide (Zepbound) - marketed for weight loss MECHANISM OF ACTION GLP-1 and GIP GLP-1 stands for "glucagon-like peptide-1," and GIP stands for "glucose-dependent insulinotropic polypeptide." GIP is also sometimes referred to as "gastric inhibitory polypeptide." GLP-1 and GIP are hormones secreted by specialized cells in the small intestine in response to food consumption
However, FDA has shown broad concern about mass-marketed non-FDA-approved GLP-1 products